Abstract
Background: Resting left ventricular outflow tract obstruction (LVOTO) occurs in 25% of patients with hypertrophic cardiomyopathy (HCM) and is an important cause of symptoms and disease progression. The prevalence and clinical significance of exercise induced LVOTO in patients with symptomatic non-obstructive HCM is uncertain. Methods and results: 87 symptomatic patients (43.3 (13.7) years, 67.8% males) with HCM and no previously documented LVOTO (defined as a gradient ≥30 mm Hg) underwent echocardiography during upright cardiopul-monary exercise testing; 54 patients (62.1%; 95% Cl 51.5 to 71.6) developed LVOTO during exercise (latent LVOTO); 33 (37.9%; 95% Cl 28.4 to 48.5) had neither resting nor exercise LVOTO (non-obstructive). Patients with latent LVOTO were more likely to have systolic anterior motion of the mitral valve (SAM) at rest (relative risk 2.1, 95% Cl 1.2 to 3.8; p = 0.01), and higher peak oxygen consumption (mean difference; 10.3%, 95% Cl 2.1 to 18.5; p = 0.02) than patients with non-obstructive HCM. The only independent predictors of Δ gradient during exercise were a history of presyncope/syncope, incomplete/complete SAM at rest and Wigle score (all p<0.05). Subsequent invasive reduction of LVOTO in 10 patients with latent obstruction and drug refractory symptoms resulted in improved functional class and less syncope/presyncope (all p<0.05). Conclusions: Approximately two-thirds of patients with symptomatic non-obstructive HCM have latent LVOTO. This study suggests that all patients with symptomatic non-obstructive HCM should have exercise stress echocardiography.
Cite
CITATION STYLE
Shah, J. S., Esteban, M. T. T., Thaman, R., Sharma, R., Mist, B., Pantazis, A., … Elliott, P. M. (2008). Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart, 94(10), 1288–1294. https://doi.org/10.1136/hrt.2007.126003
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.